Skip to main content
Top
Published in: Diabetologia 7/2005

01-07-2005 | Short Communication

Asymptomatic bacteriuria as a predictor of subsequent hospitalisation with urinary tract infection in diabetic adults: The Fremantle Diabetes Study

Authors: H. Karunajeewa, D. McGechie, G. Stuccio, N. Stingemore, W. A. Davis, T. M. E. Davis

Published in: Diabetologia | Issue 7/2005

Login to get access

Abstract

Aims/hypothesis

We examined the prognosis of well-characterised community-based diabetic patients with asymptomatic bacteriuria (ASB).

Methods

We studied 496 adults with type 1 or 2 diabetes participating in a prospective observational study. In addition to detailed clinical and laboratory data, a single mid-stream urine sample was taken for aerobic culture and antibiotic-sensitivity testing. ASB was defined as ≥105 colony-forming units/ml of one or two organisms without symptoms of urinary infection. Patients were followed for 2.9±0.6 years for hospital admission for/with urosepsis or death.

Results

Thirty-six patients (7.3%) had ASB, comprising 33 females (14.4% of all females) and three males (1.1% of all males). Only female sex predicted ASB amongst a range of variables including indices of metabolic control. Twenty-nine patients (5.8%) were subsequently hospitalised with urosepsis. Of these, urosepsis was the principal diagnosis in 12 (41%). In a Cox proportional hazards model, ASB was associated with an increased risk of hospitalisation for urosepsis as principal diagnosis (hazard ratio [95% CI] 4.4 [1.2–16.5]; p=0.004). ASB did not predict the combined endpoint of hospitalisation with urosepsis as principal or secondary diagnosis (2.3 [0.8–6.7]; p=0.12), or of non-urinary sepsis as principal (n=12) or principal/secondary (n=28) diagnosis (p>0.3).

Conclusions/interpretation

ASB identifies diabetic patients who are at significantly increased risk of subsequent urosepsis requiring hospitalisation. Further large-scale studies are needed to establish the cost-effectiveness of screening for, and pre-emptive treatment of ASB, especially in females.
Literature
1.
go back to reference Stapleton A (2002) Urinary tract infections in patients with diabetes. Am J Med 113(Suppl 1A):80S–84SCrossRefPubMed Stapleton A (2002) Urinary tract infections in patients with diabetes. Am J Med 113(Suppl 1A):80S–84SCrossRefPubMed
2.
go back to reference Geerlings SE, Stolk RP, Camps MJ et al (2001) Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 161:1421–1427CrossRefPubMed Geerlings SE, Stolk RP, Camps MJ et al (2001) Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 161:1421–1427CrossRefPubMed
3.
go back to reference Harding GK, Zhanel GG, Nicolle LE, Cheang M, Manitoba Diabetes Urinary Tract Infection Study Group (2002) Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 347:1576–1583CrossRefPubMed Harding GK, Zhanel GG, Nicolle LE, Cheang M, Manitoba Diabetes Urinary Tract Infection Study Group (2002) Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 347:1576–1583CrossRefPubMed
4.
go back to reference Davis TME, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Auto-antibodies to glutamic acid decarboxylase in diabetic patients from a multiethnic Australian community: the Fremantle Diabetes Study. Diabetic Med 17:667–674CrossRefPubMed Davis TME, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Auto-antibodies to glutamic acid decarboxylase in diabetic patients from a multiethnic Australian community: the Fremantle Diabetes Study. Diabetic Med 17:667–674CrossRefPubMed
5.
go back to reference Geerlings SE, Brouwer EC, Gaastra W, Hoepelman AI (2000) Is a second urine specimen necessary for the diagnosis of asymptomatic bacteriuria? Clin Infect Dis 31:e3–e4CrossRefPubMed Geerlings SE, Brouwer EC, Gaastra W, Hoepelman AI (2000) Is a second urine specimen necessary for the diagnosis of asymptomatic bacteriuria? Clin Infect Dis 31:e3–e4CrossRefPubMed
6.
go back to reference Gillett M, Davis WA, Jackson D, Bruce DG, Davis TME (2003) Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: The Fremantle Diabetes Study. Stroke 34:2145–2151CrossRefPubMed Gillett M, Davis WA, Jackson D, Bruce DG, Davis TME (2003) Prospective evaluation of carotid bruit as a predictor of first stroke in type 2 diabetes: The Fremantle Diabetes Study. Stroke 34:2145–2151CrossRefPubMed
7.
go back to reference Geerlings S, Stolk R, Camps M et al (2000) Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744–749PubMed Geerlings S, Stolk R, Camps M et al (2000) Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabetes Care 23:744–749PubMed
8.
go back to reference Bonadio M, Boldrini E, Forotti G et al (2004) Asymptomatic bacteriuria in women with diabetes: influence of metabolic control. Clin Infect Dis 38:e41–e45CrossRefPubMed Bonadio M, Boldrini E, Forotti G et al (2004) Asymptomatic bacteriuria in women with diabetes: influence of metabolic control. Clin Infect Dis 38:e41–e45CrossRefPubMed
9.
go back to reference Forland M, Thomas VL (1985) The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care 8:499–506PubMed Forland M, Thomas VL (1985) The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care 8:499–506PubMed
10.
go back to reference Forland M, Thomas V, Shelokov A (1977) Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria. JAMA 238:1924–1926CrossRefPubMed Forland M, Thomas V, Shelokov A (1977) Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria. JAMA 238:1924–1926CrossRefPubMed
Metadata
Title
Asymptomatic bacteriuria as a predictor of subsequent hospitalisation with urinary tract infection in diabetic adults: The Fremantle Diabetes Study
Authors
H. Karunajeewa
D. McGechie
G. Stuccio
N. Stingemore
W. A. Davis
T. M. E. Davis
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2005
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1794-3

Other articles of this Issue 7/2005

Diabetologia 7/2005 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.